Pacgen Life Science

Thursday, September 29, 2016 02:50:37 AM

Pacgen Life Science Corporation

Pacgen Life Science Corporation (formerly Pacgen Biopharmaceuticals Corporation) is a life science technology company focused on the commercialization of biomedical products and services, including its previous development of novel therapeutic drug candidates.

Oral Health Products
read more
Women Health Products
read more
Drug Development

The Company received positive results from its Phase IIb dose-ranging clinical trial for its lead product candidate, PAC-113, a novel anti-fungal drug...
read more

Pacgen, an emerging life science company based in Vancouver, Canada, is entering into a new phase of corporate growth. Through its licensing partner General Biologicals Corporation, the company has launched P113 oral health products and woman care products in Asia.

prev next

Recent News

PacGen Announces Progress on PAC-113 License
August 16, 2016
Vancouver, BC, Canada (August 16, 2016) - Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) announced today that its licensing partner, General Biologicals Corporation (“GBC...
Read more

Pacgen Closes Private Placement Financing
February 09, 2016
Vancouver, BC, Canada (February 3, 2016) - Pacgen Life Sciences Corporation, (TSX-V: PBS) (“Pacgen” or the “Company”) announced today that it has closed its previously announced non-brokered private...
Read more

Pacgen Announces Private Placement Financing and Election of New Director
January 19, 2016
Vancouver, BC, Canada (January 19, 2016) - Pacgen Life Sciences Corporation, (TSX-V: PBS) (“Pacgen” or the “Company”) announced today that it plans to complete a non-brokered private placement of up...
Read more

Pacgen Announces New Appointments
October 19, 2015
Vancouver, BC, Canada (October 15, 2015) - Pacgen Life Science Corporation, TSX-V: PBS), focused on the commercialization of innovative life sciences products, announced today the appointments of Mr...
Read more
Pacgen Provides Update on Licensed Product, PAC-113
June 18, 2015
Vancouver, BC, Canada (June 11, 2015)-Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) disclosed today that its licensing partner, General Biologicals Corporation (“GBC”) (...
Read more

Pacgen Enters into Agreement with General Biologicals Corporation
January 30, 2014
Vancouver, BC, Canada (January 24, 2014) - Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS) announced that it has entered an agreement (the “Agreement”) with General...
Read more

Pacgen Appoints Interim Chief Executive Officer
January 30, 2014
Vancouver, BC, Canada (May 8, 2013) - Pacgen Life Science Corporation (“Pacgen”) (TSX-V: PBS) announced today that Dr. Ming S. Liu has stepped down as Chief Executive Officer of the Company,...
Read more

Pacgen to exhibit at the AMP 2012 Annual Meeting in Long Beach, California
December 07, 2012
Vancouver, BC, Canada (October 23, 2012) - Pacgen Life Science Corporation (“Pacgen”) (TSX-V: PBS) announced today that it will host an exhibit at the Annual Meeting of Association for Molecular...
Read more
Pacgen Enters Into Exclusive Distribution Agreement With Arise Biotech Corporation
July 11, 2012
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 10, 2012) - Pacgen Life Science Corporation ("Pacgen" or the "Company") (PBS.V) announced today that Pacgen Inc., the Company's wholly owned subsidiary...
Read more

Pacgen Announces Name Change and New Trading Symbol
April 30, 2012
Vancouver, BC, Canada (April 30, 2012) – Pacgen Biopharmaceuticals Corporation (“Pacgen” or the “Company”) (TSX-V: PGA) announced today that it has received the TSX Venture Exchange acceptance to...
Read more

Pacgen Appoints Peter Sheu as COO
March 06, 2012
VANCOUVER, BRITISH COLUMBIA--(Marketwire -03/06/12)- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX-V: PGA.V - News) is pleased to announce the appointment of Mr. Peter Sheu...
Read more

Pacgen Expands PAC-113 License
January 30, 2012
Vancouver, BC, Canada (January 30, 2012) – Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX-V: PGA) announced today that the Company has signed an amendment to its license...
Read more

Oral Health Products

Women Health Products

Drug Development

Pacgen Life Science

Recent News